Lab
Ait Laboratories INC
Ait Laboratories INC was paid $3K by Medicaid between Dec 2020 and Oct 2024, across 13 billing codes. Its largest line is 87798, Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism — 69% of everything it billed.
33Billing provider infoAIT LABORATORIES INC
INDIANAPOLIS, IN 46241
INDIANAPOLIS, IN 46241
33aNPI1316255060assigned 09/15/2010
33bProvider typeClinical Medical Laboratory
28Total paid$3K
24GClaims3,143
24DCodes billed13
24AFirst – last monthDec 2020 – Oct 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Indiana
Rank by total paid#54 of 66
Median peer was paid$53K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 46 | $0.00 | |
| 2021 | 145 | $0.00 | |
| 2022 | 27 | $0.00 | |
| 2023 | 502 | $2K | |
| 2024incomplete | 2,423 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 69% | 1,554 | 431 | $2K |
| 87481 | 14% | 166 | 164 | $438.60 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.1% | 253 | 250 | $131.58 |
| 87653 | 4.1% | 179 | 176 | $131.58 | |
| 87529 | 2.7% | 84 | 83 | $87.72 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.7% | 75 | 73 | $87.72 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.7% | 76 | 74 | $87.72 |
| 87640 | 1.4% | 177 | 174 | $43.86 | |
| 87486 | 0% | 100 | 99 | $0.00 | |
| 87581 | 0% | 100 | 99 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 44 | 44 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 218 | 98 | $0.00 |
1 more codes
| 87631 | 0% | 117 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBAROWSKY, ROBERT (CEO)